
Description
There is preclinical evidence that the detrimental cognitive effects of hormone loss can be ameliorated by estrogen therapy (Bimonte, Acosta, & Talboom, 2010), however, one of the primary concerns with current hormone therapies is that they are nonselective, leading to increased risk of breast and endometrial cancers as well as heart disease.
Download count: 0
Details
Contributors
- Whitton, Elizabeth Nicole (Author)
- Bimonte-Nelson, Heather (Thesis director)
- Presson, Clark (Committee member)
- Baxter, Leslie (Committee member)
- Barrett, The Honors College (Contributor)
- Department of Psychology (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2013-05
Subjects
Resource Type
Collections this item is in